What does the evidence say about Curcumin Anxiety Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Curcumin Anxiety Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Background Diabetic retinopathy (DR) is a significant complication of diabetes that can adversely affect the quality of life and anthropometric indices of individuals. [Amini S (2026); evidence level 2] - This study aimed to investigate the impact of a combination of curcumin and piperine on mental health status (stress, anxiety, and depression), sleep quality, and anthropometric indices in patients with non-proliferative diabetic retinopathy. [Amini S (2026); evidence level 2] - 1 2 Depression is a leading cause of disability worldwide and is characterised by sustained low mood, anhedonia, anergia, and a range of associated cognitive and somatic symptoms []. [Muacevic Alexander (2026); evidence level 4] - This literature review summarises key randomised controlled trials (RCTs), meta-analyses, safety data, dosing patterns, and guideline positioning for saffron in depressive disorders, with emphasis on adult major depressive disorder (MDD) and related depressive symptomatology. [Muacevic Alexander (2026); evidence level 4] - Methods Crocus sativus' Databases and search strategy: A targeted search was undertaken in PubMed (primary database), with supplementary searching via Google Scholar and reference-list screening of key trials and evidence syntheses included in the bibliography. [Muacevic Alexander (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.